Artificial Intelligence (Ai) in Cancer Diagnosis and Targeting Publisher



Momtaz F ; Momtaz E ; Momtaz M ; Aboudzadeh MA ; Rahdar A
Source: Intelligent Nanocarriers: AI-Based Tools in Cancer Diagnosis and Therapy Published:2026

Abstract

Recent progress in cancer treatment has been significantly boosted by the use of Artificial Intelligence (AI) and nanotechnology. AI-driven cancer imaging methods have enhanced the precision and speed of image analysis, aiding in the early detection of cancer. They offer a novel approach in nanomedicine to enhance cancer screening and expedite treatment. Scientists are making big strides in cancer treatment by developing drug delivery systems using nanocarriers –tiny delivery vehicles that can transport medicine straight to cancer cells. This targeted approach helps reduce side effects while improving the precision and effectiveness of treatment. A major focus is the tumor microenvironment (TME), which includes factors like low oxygen levels, acidity, and specific cell activity. Understanding and adapting to these conditions is crucial for successful therapy. More recently, AI has been playing a powerful role in enhancing these nanocarrier systems. With AI, researchers can fine-tune drug properties, improve how they interact with the immune system, and boost the combined effect of multiple medications. AI also helps predict how much of a nanocarrier is needed in the TME and increases their ability to penetrate solid tumors. Now, cutting-edge AI tools are opening up new possibilities in cancer diagnosis and treatment, paving the way for smarter and more effective drug delivery in nanomedicine. © 2026 Scrivener Publishing LLC.